Changing practice of anticoagulation: will target-specific anticoagulants replace warfarin?

Arepally, Gowthami M; Ortel, Thomas L

Arepally, Gowthami M; Ortel, Thomas L.

Affiliation

Arepally GM; Division of Hematology, Department of Medicine, and.

Annu Rev Med ; 66: 241-53, 2015.

Article in En | MEDLINE | ID: mdl-25587651

Subject(s)

Anticoagulants/therapeutic use; Atrial Fibrillation/drug therapy; Stroke/prevention & control; Venous Thromboembolism/prevention & control; Warfarin/therapeutic use; Antithrombins/therapeutic use; Atrial Fibrillation/complications; Benzimidazoles/therapeutic use; Dabigatran; Factor Xa Inhibitors/therapeutic use; Humans; Morpholines/therapeutic use; Pyrazoles/therapeutic use; Pyridines/therapeutic use; Pyridones/therapeutic use; Rivaroxaban; Stroke/etiology; Thiazoles/therapeutic use; Thiophenes/therapeutic use; Venous Thromboembolism/drug therapy; beta-Alanine/analogs & derivatives; beta-Alanine/therapeutic use

Key words

factor Xa inhibitor; novel anticoagulants; thrombin inhibitor; vitamin K antagonist

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Aromoterapia Main subject: Atrial Fibrillation / Warfarin / Stroke / Venous Thromboembolism / Anticoagulants Type of study: Etiology_studies Language: En Journal: Annu Rev Med Year: 2015 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google